Tirzepatide is used in an approved branded medicine and in some advertised compounded preparations. The ingredient headline cannot by itself identify the prescribed product or its approval status. Ask for the exact product, route, and clinical rationale before comparing an enrollment price.
This page brings together the CoreAge compounded starting offer, other care models, and official Zepbound information. A branded product page is not a clinic quote. The care provider, pharmacy expense, and required monitoring must be evaluated for the actual treatment proposed.
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
Zepbound’s manufacturer record identifies tirzepatide, weight-management and specific sleep-apnea uses; savings routes and care access are separate from the medicine itself.
Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
The details, visualized
Tirzepatide evidence anchor: SURMOUNT-1
Mean reduction from baseline body weight (%)
Tirzepatide 5 mg15%
Randomized study arm; not a dosing recommendation.
Tirzepatide 10 mg19.5%
Randomized study arm; not a dosing recommendation.
Tirzepatide 15 mg20.9%
Randomized study arm; not a dosing recommendation.
Placebo3.1%
Lifestyle intervention accompanied the trial.
Group averages, not individual predictions. Doses identify trial arms, not dosing advice. These data do not establish outcomes for compounded preparations. Bars start at zero.
A result from a trial is not a result from a storefront
SURMOUNT-1 studied specified weekly tirzepatide regimens over 72 weeks. Its dose-group results are presented as research context, not a ladder for choosing treatment or a score assigned to the listed providers. A clinician determines the appropriate product and regimen.
A compounded tirzepatide offer is distinct from branded Zepbound. Request the exact preparation, dispensing pharmacy and full invoice. If a program describes branded access, establish whether its price is a membership, an insurer copay, a manufacturer offer or a pharmacy charge.
Before you decide
Questions worth answering
Does the order on this page identify the best treatment for me?
No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.
What should I verify for this comparison?
Compare the actual tirzepatide product first, then the care and pharmacy costs around it. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.
Evidence behind this page
Sources & chart notes
Checked October 7, 2026. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
Tirzepatide Plans and Product Information — keep the exact product identity and its complete label together.
Keep the brand and ingredient separate
Zepbound is an FDA-approved branded product. A compounded tirzepatide preparation is not Zepbound and should not be evaluated as an approved generic substitute. The official product profile and product distinction guide help identify the correct discussion.
Keep the brand and ingredient separate — keep the exact product identity and its complete label together.
Tie the price to the prescription
CoreAge advertises compounded tirzepatide from $129 per month. Other programs can separate care membership and medicine expenses. Confirm the ongoing invoice and pharmacy product rather than using a semaglutide promotion to estimate a tirzepatide bill.
Ask how the plan is reviewed
Treatment suitability and changes belong with the clinician. Find out how medical concerns are communicated and how refills are assessed. Read the clinical checklist before choosing from a product comparison.